IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 1, 2010
(Investigative Ophthalmology and Visual Science. )
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.09-4363

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.09-4363v1
51/3/1475    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Wang, F.
Right arrow Articles by Teng, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, F.
Right arrow Articles by Teng, Y.

S phase kinase-interacting protein 2 targeting SiRNA inhibits cell proliferation of tenon's capsule fibroblast by increasing p27 protein level

Feng Wang,1 Lin X Qi,2 Ying Su,3 Qinghui Yan,4 and Yan Teng5

1First clinical college of Harbin Medical University, Department of Ophthalmology, Harbin, China 2First clinical college of Harbin Medical University, Department of Ophthalmology, Harbin, China 3ophthalmology, ophthalmology, harbin, China 4Department of Ophthalmology, First clinical college of Harbin Medical University, harbin, China 5Department of Ophthalmology, First clinical college of Harbin Medical University, harbin, China

Correspondence: Ying Su, Email: wfsym666{at}126.com

Abstract

Objective: Although antiproliferative drugs have been used to prevent scarring after filtration surgery in patients with glaucoma, there are complications associated with their use. In the present study, we investigated wheather small interfering RNA (siRNA)-mediated gene silencing of Skp2 can be employed to increase p27 kip1 level and inhibit cell proliferation in rabbit Tenon's capsule fibroblast (rTF). Methods: A plasmid containing Skp2 siRNA was used to decrease the high constitutive level of Skp2 protein in rTF which can lead to consequent degradation of p27 kip1. Cell proliferation was assayed by immunocytochemistry using antibodies against 59-bromodeoxyuridine (BrdU) and proliferating cell neuclear antigen (PCNA). Skp2 siRNA was delivered to trabeculectomy animal model to study the effect on rTF proliferation in vivo. Results: Immunocytochemistry and Western blot showed a decreased level of Skp2 and increased level of p27 kip1 in cells transfected with pSkp2 siRNA, but not in vehicle transfection and uninfected cells in vitro and in vivo. MTT assay showed that cell viability significantly declined in rTF transfected with Skp2 siRNA. Skp2 siRNA transfected cells showed significantly less Brdu and PCNA positive staining compared with control cells in vitro and in vivo. Infitration bleb was detected in Skp2 siRNA group 14 days after trabeculectomy. Conclusions: Skp2 siRNA inhibited cell proliferation and decreased cell viability of rTF in vivo and in vitro. Our findings suggest that siRNA-mediated gene silencing of Skp2 can be a novel gene therapy to treat scarring after glaucoma surgery by suppression of p27 kip1 down-regulation.

Key Words: skp2 • p27kip1 • RNA interference • tenon’s capsule fibroblast • proliferation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the Association for Research in Vision and Ophthalmology